Literature DB >> 109536

Structural studies on induced antibodies with defined idiotypic specificities. VII. The complete amino acid sequence of the heavy chain variable region of anti-p-azophenylarsenate antibodies from A/J mice bearing a cross-reactive idiotype.

J D Capra, A Nisonoff.   

Abstract

This paper reports the complete amino acid sequence of the variable region of heavy chains derived from A/J anti-p-azophenylarsenate antibodies bearing a cross-reactive idiotype. The structure of this induced idiotypically defined antibody is homogeneous and provides the first direct evidence that heritable idiotypes are defined chemical entities. There are certain similarities between the structure of this murine antibody and the human myeloma protein Eu as well as guinea pig anti-p-azophenylarsonate antibodies. The amino acid sequence of approximately 15% of the constant region of this IgG1 molecule is also described. Combined with our studies of the variable region of the light chains of these molecules, this study represents the first complete V domain structure of an induced idiotypically defined antibody with heritable characteristics.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109536

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Complete amino acid sequence of variable domains from two monoclonal human anti-gamma globulins of the Wa cross-idiotypic group: suggestion that the J segments are involved in the structural correlate of the idiotype.

Authors:  D W Andrews; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

2.  Complete amino acid sequence of light chain variable regions derived from five monoclonal anti-p-azophenylarsonate antibodies differing with respect to a crossreactive idiotype.

Authors:  M Siegelman; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

3.  Hybridoma proteins expressing the predominant idiotype of the antiazophenylarsonate response of A/J mice.

Authors:  A Marshak-Rothstein; M Siekevitz; M N Margolies; M Mudgett-Hunter; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

4.  Structural bases for public idiotypic specificities of monoclonal antibodies directed against poly(Glu60Ala30Tyr10) and poly(Glu60Ala40) random copolymers.

Authors:  J Ruf; C Tonnelle; J Rocca-Serra; D Moinier; M Pierres; S T Ju; M E Dorf; J Thèze; M Fougereau
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

5.  Clonal recruitment and somatic mutation in the generation of immunological memory to the hapten NP.

Authors:  A Cumano; K Rajewsky
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

6.  Idiotype profile of an immune response. I. Contrasts in idiotypic dominance between primary and secondary responses and between IgM and IgG plaque-forming cells.

Authors:  J D Conger; G K Lewis; J W Goodman
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

7.  Structural studies on induced antibodies with defined idiotypic specificities. IX. Framework differences in the heavy- and light-chain-variable regions of monoclonal anti-p-azophenylarsonate antibodies from A/J mice differing with respect to a cross-reactive idiotype.

Authors:  P Estess; E Lamoyi; A Nisonoff; J D Capra
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

8.  T cell hybrids with arsonate specificity. I. Initial characterization of antigen-specific T cell products that bear a cross-reactive idiotype and determinants encoded by the murine major histocompatibility complex.

Authors:  A Pacifico; J D Capra
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

9.  Amino acid sequence diversity within the family of antibodies bearing the major antiarsonate cross-reactive idiotype of the A strain mouse.

Authors:  C A Slaughter; J D Capra
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.